Resultados de la búsqueda 171-180 of 9916 for 14-day walking program
Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
... days prior to the end of the current therapy ... days prior to the collection. Pre-myeloid ... program that can be implemented and studied in the future.
This study aims to evaluate the outcomes and patient satisfaction with same day mastectomy with or without alloplastic reconstruction following COVID-19 and ...
Study findings may help researchers design more programs that can improve memory, attention, and brain health in other women with breast cancer. The ...
... 14), but uncommon enough to have a sufficient number of patients from a ... The investigators plan to do so by developing an algorithm using fetal ...
The performance characteristics of the ddPCR assay for the detection of ctDNA mutation in uveal melanoma patients will be assessed by comparing the mutation ...
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...
... days prior to the end of the current therapy ... days prior to the collection. A Study to ... program that can be implemented and studied in the future.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?